The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer

Related articles

1. LDL-mediated chemoresistance to Lapatinib involves dysregulation of CYP3A4, SULT1A1, and HER2 signaling in HER2+ breast cancer

   This article has 10 authors:

   1. Victor Garcia-Gonzalez
   2. Ruth Areli García-Villarreal
   3. Octavio Galindo-Hernández
   4. Raúl Díaz-Molina
   5. José Luis Vique-Sánchez
   6. Nicolás Serafín-Higuera
   7. Manuel Alatorre-Meda
   8. Eustolia Rodríguez-Velázquez
   9. Angel Pulido-Capiz
   10. Brenda Chimal-Vega

2. Molecular Drivers of Progression and Therapy Resistance in Cutaneous Melanoma

   This article has 12 authors:

   1. Andreea Cătălina Tinca
   2. Adrian-Horațiu Sabău
   3. Andreea Raluca Cozac-Szoke
   4. Diana Maria Chiorean
   5. Bianca Andreea Lazar
   6. Raluca Diana Hagău
   7. Iuliu Gabriel Cocuz
   8. Raluca Niculescu
   9. Bianca Irina Kosovski
   10. Sofia Teodora Muntean
   11. Sabin Gligore Turdean
   12. Ovidiu Simion Cotoi

3. Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model

   This article has 6 authors:

   1. Mayra Xochitl Durán-Maldonado
   2. Marlene Estefania Campos-Morales
   3. Lorena Martínez-Alcantar
   4. Laura Hernández-Padilla
   5. Jesús Campos-García
   6. Ximena Hernandez-Ramos